Inhibitor Drug Entinostat 'Primes' the Body to Better Respond to Anti-Cancer Treatment with Immunotherapy – India Education | Latest Education News | Global Educational News
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers
United States University Of Southern California Molly Geare David Lim Elizabethm Jaffee Chenguang Wang
Source: indiaeducationdiary.in